About

Chris A. is a tech-savvy engineer turned serial entrepreneur turned venture capitalist. With over 13 years of relevant experience, he is currently the founder of A2Z Venture Capital and an investor in Coligomed. His focus is on machine learning/artificial intelligence and healthcare, fueling the techceleration in healthcare. Chris strongly believes in putting people first and that excellence should be pursued, with success following naturally. A2Z Venture Capital is a seed-stage venture capital firm that invests in and partners with founders, entrepreneurs, and management teams to create market-leading healthcare service businesses. Chris leverages his deep expertise and connections in the healthcare sector, as well as his hands-on partnering approach, to successfully drive development and optimize value. Chris has a Master of Science in Applied Computing from the University of Toronto, a Master of Business Administration from Stanford University, and an MBA (Visiting Student) from the University of Toronto - Rotman School of Management. He also holds a Bachelor of Engineering from Carleton University. Chris has worked with various companies in the past, including Creative Destruction Lab and Global Health Impact Network, as an advisor in the healthcare sector. He is well-versed in the tech stack of AI and ML, which he uses to drive innovation in healthcare. Overall, Chris is a global investor in AI in healthcare, with a keen eye for identifying and partnering with founders and entrepreneurs to create market-leading healthcare service businesses.